Diabetes
News
Lyumjev ultra-rapid-acting insulin gets FDA nod
The novel rapid-acting formulation of insulin lispro is approved for adults with type 1 and type 2 diabetes.
From the Journals
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that...
Conference Coverage
Dapagliflozin’s T2D renal protection extends to ‘fast decline’ of eGFR
Another dimension of dapagliflozin’s renal protection for type 2 diabetes patients is shown in a post-hoc analysis from its cardiovascular...
Conference Coverage
Frequent hypoglycemic episodes raise cardiac event risk
It’s “essential” to avoid drugs associated with hypoglycemia to minimize CV event risk in patients with type 2 diabetes, investigator says.
Conference Coverage
Novel insulin shows early promise for once-weekly treatment
With similar efficacy and safety to insulin glargine U100, if findings are confirmed in phase 3 and product is approved, it could be the first-...
Conference Coverage
DAPA-HF: Dapagliflozin slows T2D onset in heart failure patients
Latest News
Daily Recap: FDA revokes emergency use of hydroxychloroquine; Hardest hit specialties ranked in financial report
Volunteer “street medics” -- nursing students, veterinarians, doctors, trauma surgeons, security guards, ski patrollers, nurses, wilderness EMTs,...
Conference Coverage
For COVID-19 plus diabetes, glycemic control tops treatment list
Tight glucose control led to better results in patients with diabetes and COVID-19.
Conference Coverage
Diabetes hospitalizations halved with FreeStyle Libre glucose monitor
Hospitalizations for diabetic ketoacidosis, diabetes-related emergencies, and all-cause hospitalizations were reduced following initiation of...
Conference Coverage
CV outcomes of SGLT2 inhibitors and GLP-1 agonists compared in real-world study
Conference Coverage
High-frequency spinal cord stimulation eases painful diabetic neuropathy